Nomura Holdings’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-154,439
| Closed | -$11.4M | – | 808 |
|
2025
Q1 | $11.4M | Buy |
154,439
+86,218
| +126% | +$6.34M | 0.02% | 182 |
|
2024
Q4 | $4.47M | Buy |
68,221
+17,241
| +34% | +$1.13M | 0.01% | 400 |
|
2024
Q3 | $3.97M | Buy |
+50,980
| New | +$3.97M | 0.01% | 335 |
|
2024
Q1 | – | Hold |
0
| – | – | – | 993 |
|
2023
Q4 | – | Hold |
0
| – | – | – | 1159 |
|
2023
Q2 | – | Sell |
-16,001
| Closed | -$1.11M | – | 819 |
|
2023
Q1 | $1.11M | Sell |
16,001
-16,750
| -51% | -$1.16M | ﹤0.01% | 515 |
|
2022
Q4 | $2.22M | Buy |
32,751
+11,671
| +55% | +$791K | 0.01% | 383 |
|
2022
Q3 | $1.16M | Sell |
21,080
-20,254
| -49% | -$1.11M | ﹤0.01% | 547 |
|
2022
Q2 | $2.77M | Buy |
41,334
+3,833
| +10% | +$257K | 0.01% | 431 |
|
2022
Q1 | $2.52M | Sell |
37,501
-12,000
| -24% | -$805K | 0.01% | 504 |
|
2021
Q4 | $2.88M | Sell |
49,501
-11,000
| -18% | -$641K | 0.01% | 547 |
|
2021
Q3 | $3.61M | Buy |
60,501
+44,251
| +272% | +$2.64M | 0.01% | 473 |
|
2021
Q2 | $978K | Buy |
16,250
+7,250
| +81% | +$436K | ﹤0.01% | 757 |
|
2021
Q1 | $450K | Buy |
+9,000
| New | +$450K | ﹤0.01% | 1023 |
|
2015
Q2 | – | Sell |
-55,000
| Closed | -$1.89M | – | 1420 |
|
2015
Q1 | $1.89M | Buy |
55,000
+53,696
| +4,118% | +$1.84M | 0.01% | 367 |
|
2014
Q4 | $46K | Sell |
1,304
-1,698
| -57% | -$59.9K | ﹤0.01% | 1430 |
|
2014
Q3 | $107K | Sell |
3,002
-93,036
| -97% | -$3.32M | ﹤0.01% | 1679 |
|
2014
Q2 | $3.57M | Buy |
96,038
+62,192
| +184% | +$2.31M | ﹤0.01% | 369 |
|
2014
Q1 | $1.1M | Sell |
33,846
-49,992
| -60% | -$1.62M | ﹤0.01% | 875 |
|
2013
Q4 | $2.47M | Buy |
83,838
+51,312
| +158% | +$1.51M | 0.01% | 521 |
|
2013
Q3 | $842K | Buy |
+32,526
| New | +$842K | 0.01% | 1057 |
|